Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
INVESTING
ImmunoGen Plunges as FDA Rejects Fast-Track Approval for Cancer Drug
By M. Corey Goldman
May 15, 2019 9:31 AM EDT
PRESS RELEASES
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
By Business Wire
Feb 1, 2021 4:30 PM EST
PRESS RELEASES
ImmunoGen Announces Conference Call To Discuss Its 2020 Operating Results
By Business Wire
Jan 29, 2021 4:01 PM EST
PRESS RELEASES
ImmunoGen Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
By Business Wire
Jan 4, 2021 4:30 PM EST
PRESS RELEASES
ImmunoGen Announces Webcast Of Presentation And Q&A At The 39th Annual J.P. Morgan Healthcare Conference
By Business Wire
Dec 30, 2020 4:30 PM EST
PRESS RELEASES
ImmunoGen Presents Updated Findings From Phase 1/2 Study Of IMGN632 In Blastic Plasmacytoid Dendritic Cell Neoplasm At ASH Annual Meeting
By Business Wire
Dec 5, 2020 3:01 PM EST
PRESS RELEASES
ImmunoGen Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
By Business Wire
Dec 1, 2020 4:30 PM EST
PRESS RELEASES
ImmunoGen Announces Conference Call To Discuss Recent Updates For IMGN632 In Blastic Plasmacytoid Dendritic Cell Neoplasm And Acute Myeloid Leukemia
By Business Wire
Nov 30, 2020 4:30 PM EST
PRESS RELEASES
ImmunoGen Announces Webcasts Of Presentations At Upcoming Virtual Conferences
By Business Wire
Nov 18, 2020 4:30 PM EST
PRESS RELEASES
ImmunoGen Announces Webcast Of Presentation At Upcoming Jefferies Virtual London Healthcare Conference
By Business Wire
Nov 4, 2020 4:30 PM EST
PRESS RELEASES
ImmunoGen Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
By Business Wire
Nov 2, 2020 4:30 PM EST
PRESS RELEASES
ImmunoGen Announces Conference Call To Discuss Its Third Quarter 2020 Operating Results
By Business Wire
Oct 22, 2020 4:01 PM EDT
PRESS RELEASES
ImmunoGen And Huadong Medicine Announce Strategic Collaboration To Develop And Commercialize Mirvetuximab Soravtansine In Greater China
By Business Wire
Oct 19, 2020 8:45 AM EDT
PRESS RELEASES
ImmunoGen Raises $54.8 Million In Gross Proceeds Through Its At-the-Market Facility
By Business Wire
Oct 12, 2020 6:30 AM EDT
PRESS RELEASES
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
By Business Wire
Oct 1, 2020 4:30 PM EDT
PRESS RELEASES
ImmunoGen Presents Final Data From Phase 1b FORWARD II Triplet Cohort Evaluating Mirvetuximab Soravtansine In Combination With Carboplatin And Avastin® At ESMO
By Business Wire
Sep 17, 2020 3:01 AM EDT
PRESS RELEASES
ImmunoGen Announces Webcast Of Presentation At Upcoming H.C. Wainwright Virtual Global Investment Conference
By Business Wire
Sep 2, 2020 4:30 PM EDT
PRESS RELEASES
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
By Business Wire
Sep 1, 2020 4:30 PM EDT
PRESS RELEASES
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
By Business Wire
Aug 3, 2020 4:30 PM EDT
PRESS RELEASES
ImmunoGen Announces Webcast Of Presentation At Upcoming Canaccord Genuity Virtual Growth Conference
By Business Wire
Jul 29, 2020 4:30 PM EDT
PRESS RELEASES
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
By Business Wire
Jul 22, 2020 8:00 AM EDT
PRESS RELEASES
ImmunoGen Appoints Susan Altschuller, PhD As Senior Vice President And Chief Financial Officer
By Business Wire
Jul 20, 2020 7:00 AM EDT
PRESS RELEASES
ImmunoGen Announces Conference Call To Discuss Its Second Quarter 2020 Operating Results
By Business Wire
Jul 16, 2020 4:01 PM EDT
PRESS RELEASES
ImmunoGen Presents Preclinical Data On IMGN151 At Virtual AACR Annual Meeting
By Business Wire
Jun 22, 2020 9:01 AM EDT
PRESS RELEASES
ImmunoGen Announces Virtual 2020 Annual Meeting Of Shareholders
By Business Wire
Jun 3, 2020 8:00 AM EDT
